Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sarav Kaliyaperumal"'
Autor:
Cong Li, Gregory Moore, Umesh Muchhal, John Desjarlais, Matthew Bernett, Madeline Fort, Lingming Liang, Tao Osgood, Rodolfo Yabut, Sarav Kaliyaperumal, John Harrold, Jude Canon, Anna Rogojina, Raushan Kurmasheva, Peter Houghton, Olivier Nolan-Stevaux
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/9f44cfaebbde4a72a66c6cbe35d25b0b
Autor:
Tod Harper, Amy Sharma, Sarav Kaliyaperumal, Flordeliza Fajardo, Katie Hsu, Lily Liu, Rhian Davies, Yu-Ling Wei, Jinghui Zhan, Juan Estrada, Majk Kvesic, Lisa Nahrwold, Wibke Deisting, Marc Panzer, Keegan Cooke, Hervé Lebrec, Olivier Nolan-Stevaux
Publikováno v:
Toxicological Sciences. 189:32-50
Bispecific T-cell engager (BiTE) molecules have great potential to treat cancer. Nevertheless, dependent on the targeted tumor antigen, the mechanism of action that drives efficacy may also contribute to on-target/off-tumor toxicities. In this study,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::774f0bed25671619c33c61ea448cae63
https://doi.org/10.1093/toxsci/kfac052
https://doi.org/10.1093/toxsci/kfac052
Autor:
Raushan Kurmasheva, Olivier Nolan-Stevaux, John R. Desjarlais, Matthew J. Bernett, Peter J. Houghton, Rodolfo Yabut, Cong Li, Tao Osgood, Anna Rogojina, Umesh Muchhal, Madeline M. Fort, Jude Canon, Gregory T. Moore, John M. Harrold, Sarav Kaliyaperumal, Lingming Liang
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Metastatic castration-resistant prostate cancer (mCRPC) and Ewing sarcoma (EWS) are diseases for which immune therapies could potentially provide benefit. STEAP1 (Six Transmembrane Epithelial Antigen of the Prostate 1) is a cell surface pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d76db3a38e8fb53797b6ab1ab10f35a2
https://doaj.org/article/9f44cfaebbde4a72a66c6cbe35d25b0b
https://doaj.org/article/9f44cfaebbde4a72a66c6cbe35d25b0b
Autor:
Razvan Cristescu, Kallol Ray, Jennifer H. Yearley, Douglas Linn, Brian Long, Shuli Zhang, Sripriya Dhandapani, Sarav Kaliyaperumal
Publikováno v:
Cancer Research. 77:1657-1657
Targeting immune checkpoints has proven to be an effective strategy for reactivating the immune system to elicit potent anti-tumor activity. For example, the anti-PD-1 antibody pembrolizumab has shown robust and durable clinical activity in numerous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd66140947a7f53edf59a149bf57bdbc
https://doi.org/10.1158/1538-7445.am2017-1657
https://doi.org/10.1158/1538-7445.am2017-1657
Autor:
Cavicchioli, Laura, Susan, Westmoreland, Ferraresso, Serena, Sarav, Kaliyaperumal, Marta, Vadori, Claire, Crossan, Linda, Scobie, DE BENEDICTIS, GIULIA MARIA, Annalisa, Stefani, Denaro, Luca, D'Avella, Domenico, Romina Aron Badin, Cozzi, Emanuele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3657::dc6aeec1c607cc9ff0f5845cd5aada30
http://hdl.handle.net/11577/3033537
http://hdl.handle.net/11577/3033537
Autor:
Cavicchioli, Laura, Susan, Westmoreland, Ferraresso, Serena, Martina, Carniel, Andrea, Danesi, Palmisano, Giuseppe, Sarav, Kaliyaperumal, Marta, Vadori, Cozzi, Emanuele, Castagnaro, Massimo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3657::df663a3ca0622a206058327095827505
http://hdl.handle.net/11577/3033616
http://hdl.handle.net/11577/3033616